nih-gov/ncats.nih.gov/news-events/news/large-clinical-trial-to-study-repurposed-drugs-to-treat-covid-19-symptoms
2025-02-26 13:17:41 -05:00

475 lines
43 KiB
Text
Raw Permalink Blame History

This file contains ambiguous Unicode characters

This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.

<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
<head>
<meta charset="utf-8" />
<meta name="description" content="CTSA Program implements a large clinical trial for mild to moderate COVID-19 to test several existing drugs, including ivermectin, fluvoxamine and fluticasone." />
<meta name="keywords" content="ACTIV-6, ACTIV, accelerating the COVID-19 therapeutic interventions and vaccines, COVID-19, SARS-CoV-2, CTSA Program, clinical and translational science awards program, FDA, NIH, clinical trial, drug repurposing, community engagement" />
<link rel="canonical" href="http://ncats.nih.gov/news-events/news/large-clinical-trial-to-study-repurposed-drugs-to-treat-covid-19-symptoms" />
<meta name="google" content="PROqkJCbtNawPO29xzL4ENjcb0_EckySw96i97QXx8s" />
<meta name="google-site-verification" content="PROqkJCbtNawPO29xzL4ENjcb0_EckySw96i97QXx8s" />
<meta name="Generator" content="Drupal 10 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<link rel="icon" href="/themes/custom/d9_subtheme/assets/images/favicon.ico" type="image/vnd.microsoft.icon" />
<title>Large Clinical Trial to Study Repurposed Drugs to Treat COVID-19 Symptoms | National Center for Advancing Translational Sciences</title>
<link rel="stylesheet" media="all" href="/libraries/drupal-superfish/css/superfish.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/ajax-progress.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/align.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/autocomplete-loading.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/fieldgroup.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/container-inline.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/clearfix.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/details.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/hidden.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/item-list.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/js.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/nowrap.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/position-container.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/progress.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/reset-appearance.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/resize.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/sticky-header.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/system-status-counter.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/system-status-report-counters.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/system-status-report-general-info.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/tabledrag.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/tablesort.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/system/css/components/tree-child.module.css?srmo5o" />
<link rel="stylesheet" media="all" href="/modules/contrib/extlink/extlink.css?srmo5o" />
<link rel="stylesheet" media="all" href="/core/modules/layout_discovery/layouts/onecol/onecol.css?srmo5o" />
<link rel="stylesheet" media="all" href="https://cdn.jsdelivr.net/npm/@uswds/uswds@3.3.0/dist/css/uswds.min.css" />
<link rel="stylesheet" media="all" href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.2/dist/css/bootstrap.min.css" />
<link rel="stylesheet" media="all" href="https://cdn.jsdelivr.net/npm/bootstrap-icons@1.11.1/font/bootstrap-icons.css" />
<link rel="stylesheet" media="all" href="/themes/custom/d9_subtheme/css/styles.css?srmo5o" />
<script src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&amp;subagency=NIH" id="_fed_an_ua_tag" async type="text/javascript"></script>
</head>
<body class="path-node page-node-type-level3">
<a href="#main-content" class="usa-sr-only focusable">
Skip to main content
</a>
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-55CGV66V"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
<section class="navigation-top">
<div class="container">
<div class="row">
<div class="col-12">
<div class="link-small d-flex">
<a href="http://www.hhs.gov/" title="Go to the hhs.gov" class="" target="_blank">
<img src="/sites/default/files/2023-10/hhs-white.png" alt="HHS Logo">
<span class="d-xl-inline d-lg-inline d-none small">U.S. Department of Health &amp; Human Services</span>
</a>
<a href="http://www.nih.gov/" title="National Institutes of Health | Homepage" class="" target="_blank">
<img src="/sites/default/files/2023-10/nih-logo.png" alt="NIH Logo">
<span class="d-xl-inline d-lg-inline d-none small">National Institutes of Health</span>
</a>
</div>
</div>
</div>
</div>
</section>
<div class="usa-overlay"></div>
<header class="usa-header usa-header--extended usa-header--extended-megamenu" id="header" role="banner">
<div class="region region-header grid-container">
<div class="grid-row grid-gap-1"><div class="desktop:grid-col-3 header-first">
<div class="usa-logo site-logo" id="logo">
<em class="usa-logo__text">
<a class="logo-img" href="/" accesskey="1" title="Home" aria-label="Home">
<img src="/themes/custom/d9_subtheme/logo.png" alt="Home" />
</a>
</em>
</div>
<div class="search-icon d-md-none"><a class="toggle-search" href="#"><i class="bi bi-search"></i></a></div>
</div><div class="desktop:grid-col-7">
<div id="block-navigation" class="block block-superfish block-superfishnavigation">
<ul id="superfish-navigation" class="menu sf-menu sf-navigation sf-horizontal sf-style-none">
<li id="navigation-menu-link-contentaed842ec-f581-4cea-b0b0-4a85c50def86" class="sf-depth-1 menuparent"><a href="/research" class="sf-depth-1 menuparent">Research</a><ul><li id="navigation-menu-link-content5a3b6aac-7ae9-45d7-929f-fbf776db20f0" class="sf-depth-2 sf-no-children"><a href="/research/overview" class="sf-depth-2">Research Overview</a></li><li id="navigation-menu-link-contentd0507d8b-7b88-453c-908a-2b7e961c0479" class="sf-depth-2 sf-no-children"><a href="/research/our-impact" class="sf-depth-2">Our Impact</a></li><li id="navigation-menu-link-contented530d1e-2ec3-46db-a529-9029be3f3fb4" class="sf-depth-2 sf-no-children"><a href="/research/research-activities" class="sf-depth-2">Research Activities</a></li><li id="navigation-menu-link-content2dac8545-38f2-47c0-8993-ea0cae65e123" class="sf-depth-2 sf-no-children"><a href="/research/research-resources" class="sf-depth-2">Research Resources</a></li><li id="navigation-menu-link-content311ec98e-6232-4e22-9966-4a9ac796870a" class="sf-depth-2 sf-no-children"><a href="/research/training-education" class="sf-depth-2">Training &amp; Education</a></li><li id="navigation-menu-link-content52b1ba41-94ea-4d84-9db7-7482b8f78f16" class="sf-depth-2 sf-no-children"><a href="/research/alliances" class="sf-depth-2">Alliances</a></li><li id="navigation-menu-link-contenta185af75-90a5-4cc4-813f-ef66f35e21ea" class="sf-depth-2 sf-no-children"><a href="/research/collaborate-with-ncats" class="sf-depth-2">Collaborate With NCATS</a></li></ul></li><li id="navigation-menu-link-content84a3cc1f-203d-4de6-ab26-d80c256b96dc" class="sf-depth-1 menuparent"><a href="/funding" class="sf-depth-1 menuparent">Funding</a><ul><li id="navigation-menu-link-content0a09bed2-3d99-4faf-b3c5-fc9a4878629a" class="sf-depth-2 sf-no-children"><a href="/funding/overview" class="sf-depth-2">Funding Overview</a></li><li id="navigation-menu-link-contentd85a1f38-7893-4e4a-8514-5b9e767983e2" class="sf-depth-2 sf-no-children"><a href="/funding/funding-opportunities" class="sf-depth-2">Open Funding Opportunities</a></li><li id="navigation-menu-link-content81e84c00-ef73-4aff-a15f-7728cc398801" class="sf-depth-2 sf-no-children"><a href="/funding/small-business-programs" class="sf-depth-2">Small Business Programs</a></li><li id="navigation-menu-link-content631a166b-650b-450f-97b4-9014d14935e9" class="sf-depth-2 sf-no-children"><a href="/funding/funding-policy-operating-guidelines" class="sf-depth-2">Funding Policy &amp; Operating Guidelines</a></li><li id="navigation-menu-link-content5d56ebe7-b3e8-452a-bd30-df92b0deabef" class="sf-depth-2 sf-no-children"><a href="/funding/grant-information" class="sf-depth-2">Grant Information</a></li><li id="navigation-menu-link-content4429fdc9-e911-4022-b3dc-3f6a4980b9ff" class="sf-depth-2 sf-no-children"><a href="/funding/challenges" class="sf-depth-2">Challenges and Prize Competitions</a></li><li id="navigation-menu-link-content943fe682-94ff-4fcf-a6b0-32096d2b2d0e" class="sf-depth-2 sf-no-children"><a href="/funding/scientific-review" class="sf-depth-2">Scientific Review</a></li><li id="navigation-menu-link-content10496705-320e-4437-b2ba-ea2830b293d1" class="sf-depth-2 sf-no-children"><a href="/funding/conference-grant-information" class="sf-depth-2">Conference Grant Information</a></li></ul></li><li id="navigation-menu-link-contentea91f2ef-1b8d-4b1c-83e7-5830769dd505" class="sf-depth-1 menuparent"><a href="/resources" class="sf-depth-1 menuparent">Resources For You</a><ul><li id="navigation-menu-link-content567e64e3-685d-41bc-8bf4-130c7689d6a2" class="sf-depth-2 sf-no-children"><a href="/resources/overview" title="Resources for You" class="sf-depth-2">Resources for You</a></li><li id="navigation-menu-link-content786ce1f5-ff7a-463a-bb05-c01882062426" class="sf-depth-2 sf-no-children"><a href="/resources/for-researchers" title="Resources for Researchers" class="sf-depth-2">Resources for Researchers</a></li><li id="navigation-menu-link-contente737ec67-ecd0-4f18-915d-b61660cb524f" class="sf-depth-2 sf-no-children"><a href="/resources/for-trainees" title="Resources for Trainees" class="sf-depth-2">Resources for Trainees</a></li><li id="navigation-menu-link-content8812fdb6-0fb7-4b27-8401-2fc5b3f41ff1" class="sf-depth-2 sf-no-children"><a href="/resources/for-rare-disease-patients-and-advocates" title="Resources for Rare Disease Patients and Advocates" class="sf-depth-2">Resources for Rare Disease Patients and Advocates</a></li></ul></li><li id="navigation-menu-link-contenta8527040-df23-4117-a5a7-566bd83e2c7f" class="sf-depth-1 menuparent"><a href="/news-events" class="sf-depth-1 menuparent">News &amp; Events</a><ul><li id="navigation-menu-link-contentf6836a81-a42a-4528-b569-18939d8451da" class="sf-depth-2 sf-no-children"><a href="/news-events/overview" class="sf-depth-2">News &amp; Events Overview</a></li><li id="navigation-menu-link-content9f44edc6-e5b7-4a92-bcb3-c0a8777461f4" class="sf-depth-2 sf-no-children"><a href="/news-events/news" class="sf-depth-2">News</a></li><li id="navigation-menu-link-content402cff9f-12b7-459b-9f0f-56606930399c" class="sf-depth-2 sf-no-children"><a href="/news-events/newsletter" class="sf-depth-2">Newsletters</a></li><li id="navigation-menu-link-content6cd76cbe-053e-4e3b-8961-c9f5def57ba6" class="sf-depth-2 sf-no-children"><a href="/news-events/events" class="sf-depth-2">Events</a></li><li id="navigation-menu-link-content0a211675-2fb5-45cc-b443-c7946e7d9120" class="sf-depth-2 sf-no-children"><a href="/news-events/science-publications" class="sf-depth-2">Scientific Publications</a></li><li id="navigation-menu-link-contente6d4ed4f-826f-41b4-a9e2-728c2fb4ca62" class="sf-depth-2 sf-no-children"><a href="/news-events/multimedia" class="sf-depth-2">Multimedia</a></li></ul></li><li id="navigation-menu-link-contentf1eb1fa8-5813-433c-9bcc-dc56f2e258f3" class="sf-depth-1 menuparent"><a href="/about" class="sf-depth-1 menuparent">About NCATS</a><ul><li id="navigation-menu-link-contentada9a195-ae5a-446a-9014-c1232164e6db" class="sf-depth-2 sf-no-children"><a href="/about/ncats-overview" class="sf-depth-2">NCATS Overview</a></li><li id="navigation-menu-link-contentd5e0369a-aded-4348-84f7-463c64498447" class="sf-depth-2 sf-no-children"><a href="/about/about-translational-science" class="sf-depth-2">About Translational Science</a></li><li id="navigation-menu-link-contente298b7b2-724e-408b-9bb9-afcaac57a751" class="sf-depth-2 sf-no-children"><a href="/about/advisory-committees" class="sf-depth-2">Advisory Committees</a></li><li id="navigation-menu-link-contentbc9c91b7-8d3d-4d2c-af65-c25ef894d269" class="sf-depth-2 sf-no-children"><a href="/about/budget" class="sf-depth-2">Budget</a></li><li id="navigation-menu-link-contenta4ed4439-05db-4a41-9357-731c2ff74543" class="sf-depth-2 sf-no-children"><a href="/about/director" class="sf-depth-2">Director&#039;s Corner</a></li><li id="navigation-menu-link-contentb50f96af-3723-4634-8566-4e60c2639491" class="sf-depth-2 sf-no-children"><a href="/about/divisions-and-offices" class="sf-depth-2">Divisions &amp; Offices</a></li><li id="navigation-menu-link-content41d11ad4-c576-46be-a326-1f8cf5059354" class="sf-depth-2 sf-no-children"><a href="/about/our-staff" class="sf-depth-2">Our Staff</a></li></ul></li>
</ul>
</div>
</div>
<div class="desktop:grid-col-2 search-block">
<form class="usa-search usa-search--small" action="/search/node" method="get" id="search-block-form" accept-charset="UTF-8">
<div role="search">
<input class="usa-input" id="extended-search-field-small" type="search" name="keys" />
<button class="usa-button" type="submit">
<img src="/themes/custom/d9_subtheme/node_modules/@uswds/uswds/dist/img/usa-icons-bg/search--white.svg" class="usa-search__submit-icon" alt="Search">
</button>
</div>
</form>
</div></div>
</div>
<nav class="usa-nav" role="navigation">
<div class="usa-nav__inner">
<button type="button" class="usa-nav__close">
<img src="/themes/custom/d9_subtheme/node_modules/@uswds/uswds/dist/img/usa-icons/close.svg" alt="close"/>
</button>
</div>
</nav>
</header>
<main class="main-content usa-layout-docs usa-section " role="main"
id="main-content">
<div class="grid-container-">
<div class="grid-row">
</div>
<div class="">
</div>
<div class="grid-row ">
</div>
<div class="grid-row grid-gap">
<div class="usa-layout-docs__main desktop:grid-col-fill">
<div class="">
<div data-drupal-messages-fallback class="hidden"></div>
<div id="block-d9-subtheme-content" class="block block-system block-system-main-block">
<article data-history-node-id="20079">
<div>
<div class="container layout layout--onecol">
<div class="layout__region layout__region--content">
<div class="block block-system block-system-breadcrumb-block">
<nav class="usa-breadcrumb" role="navigation" aria-labelledby="system-breadcrumb">
<h2 id="system-breadcrumb" class="usa-sr-only">Breadcrumb</h2>
<ol class="usa-breadcrumb__list">
<li class="usa-breadcrumb__list-item">
<a href="/" class="usa-breadcrumb__link"><span>Home</span></a>
</li>
<li class="usa-breadcrumb__list-item">
<a href="/news-events/overview" class="usa-breadcrumb__link"><span>News &amp; Events</span></a>
</li>
<li class="usa-breadcrumb__list-item">
<a href="/news-events/news" class="usa-breadcrumb__link"><span>News</span></a>
</li>
<li class="usa-breadcrumb__list-item">
<span>Large Clinical Trial To Study Repurposed Drugs To Treat COVID-19 Symptoms</span>
</li>
</ol>
</nav>
</div>
<div class="block block-layout-builder block-extra-field-blocknodelevel3content-moderation-control">
</div>
</div>
</div>
<div class="container layout layout--onecol">
<div class="layout__region layout__region--content">
<div class="block block-layout-builder block-field-blocknodelevel3title">
<h1 class="page-title">Large Clinical Trial to Study Repurposed Drugs to Treat COVID-19 Symptoms</h1>
</div>
<div class="block block-layout-builder block-field-blocknodelevel3body">
<style type="text/css">li {
color: #000;
}
.panel {
margin-bottom: 10px;
}
.panel-heading,
p &amp;amp;amp;amp;amp;amp;gt; strong,
li &amp;amp;amp;amp;amp;amp;gt; strong {
color: #333;
}
.panel-body {
padding: 15px;
}
div &amp;amp;amp;amp;amp;amp;gt; div.panel-heading &amp;amp;amp;amp;amp;amp;gt; div &amp;amp;amp;amp;amp;amp;gt; div.col-xs-9 &amp;amp;amp;amp;amp;amp;gt; div &amp;amp;amp;amp;amp;amp;gt; h3 {
font-size: 15px;
color: #fff;
}
.question {
margin: 0 15px;
}
div.panel-body &amp;amp;amp;amp;amp;amp;gt; p:nth-last-child(1) {
margin-bottom: 0;
}
</style><div style="background-color:#E3EBED;margin:12px 0;padding:20px;"><p style="margin:0;padding:0;">Read the <a href="https://jamanetwork.com/journals/jama/fullarticle/2797483">ivermectin 400</a>,&nbsp;<a href="https://jamanetwork.com/journals/jama/fullarticle/2801827">ivermectin 600</a>, <a href="https://jamanetwork.com/journals/jama/fullarticle/2800448">fluvoxamine 50</a>, <a href="https://jamanetwork.com/journals/jama/fullarticle/2812204">fluvoxamine 100</a>, and <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2209421">fluticasone</a> peer-reviewed publication, and the <a href="https://www.medrxiv.org/content/10.1101/2024.05.16.24307115v1">montelukast</a> preprint.&nbsp;<o:p></o:p></p></div><div class="caption-right-md" style="margin-right:0;"><img class="img-responsive" src="/sites/default/files/ACTIV-6_900x600px.jpg" alt="Creative rendition of SARS-CoV-2 virus particles." width="900" height="600"><div class="caption-text"><p>Creative rendition of SARS-CoV-2 virus particles. Note: not to scale. <em>(NIAID)</em></p></div></div><p>April 19, 2021&nbsp;</p><p><em>Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness</em></p><p>The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) publicprivate partnership, the ACTIV-6 trial aims to provide evidence-based treatment options for the majority of adult patients with COVID-19 who have mild-to-moderate symptoms and are not sick enough to be hospitalized. NIH will provide an initial investment of $155 million in funding for the trial.</p><p>“While were doing a good job with treating hospitalized patients with severe disease, we dont currently have an approved medication that can be self-administered to ease symptoms of people suffering from mild disease at home, and reduce the chance of their needing hospitalization,” said NIH Director Francis S. Collins, M.D., Ph.D. “ACTIV-6 will evaluate whether certain drugs showing promise in small trials can pass the rigor of a larger trial.”</p><p>Several drugs currently are recommended for the treatment of hospitalized patients with moderate to severe COVID-19, including the antiviral drug remdesivir, the anti-inflammatory baricitinib, and corticosteroids. Additionally, the U.S. Food and Drug Administration authorized emergency use of intravenous monoclonal antibodies in non-hospitalized patients with mild to moderate COVID-19 who are at high risk for severe disease. However, medications that can be self-administered at home to reduce COVID-19 symptoms are critically needed.</p><p>The ACTIV-6 protocol will explore a pool of up to seven drugs approved by FDA for other conditions — an approach called drug repurposing — and test their safety and effectiveness in treating mild to moderate COVID-19. Because the drugs under consideration already have been tested in humans, repurposing could deliver COVID-19 treatment options sooner. Drugs will be administered orally or by inhaler and will be easy for participants to take at home. Participants will be assigned randomly to receive either a placebo or one of the treatments, which will be sent to them by mail.</p><p>Enrollment is expected to open in a few weeks to up to 13,500 participants who are at least 30 years old, have tested positive for SARS-CoV-2 infection and have experienced two or more mild-to-moderate symptoms of COVID-19 for no more than seven days. Researchers plan to assess changes in patients symptoms over a 14-day period, as well as hospitalizations and deaths over a 28-day period. They also will assess long-term COVID-19-related symptoms at 90 days after treatment begins. The list of drugs that will be added to the study arms is still being finalized. All the drugs will have established safety records and early indications from smaller or less controlled studies of effectiveness against COVID-19.</p><p>The trial will focus on enrollment of people within minority, rural and other communities that are significantly affected by COVID-19 but lack access to major academic medical centers, where large clinical trials usually take place.</p><p>With funding provided by the American Rescue Plan Act, NIHs National Center for Advancing Translational Sciences (NCATS) will oversee the trial. The Duke Clinical Research Institute, Durham, North Carolina, an NCATS-funded <a href="/ctsa" title="Clinical and Translational Science Awards (CTSA) Program">Clinical and Translational Science Awards (CTSA) Program</a> hub, will serve as the clinical coordinating center, and the Vanderbilt Institute for Clinical and Translational Research CTSA Program hub at Vanderbilt University Medical Center, Nashville, Tennessee, will serve as the trials data coordinating center.</p><p>To expedite enrollment in ACTIV-6, NCATS and its Duke-Vanderbilt Trial Innovation Center will partner with the Patient-Centered Outcomes Research Institute (PCORI), an independent nonprofit research funding organization. PCORnet, the National Patient-Centered Clinical Research Network, which is funded by PCORI, will support the ACTIV-6 governance and operations. In addition, PCORnet sites will enroll participants from a broad range of communities.</p><p>“Getting approval for a new drug to come to market usually takes years,” said Joni Rutter, Ph.D., NCATS acting director. “By leveraging drug repurposing and existing national clinical trial networks, ACTIV-6 aims to speed the delivery of definitive answers about available drugs that could help people manage COVID-19 symptoms at home.”</p><p>Media Contact: NCATS Information Officer, <a href="mailto:ncatsinfo@mail.nih.gov">ncatsinfo@mail.nih.gov</a></p><h2>Questions &amp; Answers</h2><div class="row"><div class="question" id="question-one" name="question-one"><div class="panel panel-default"><div class="panel-heading" style="background-color:#006478;color:#fff;padding:5px 15px;"><div class="row"><div class="col-xs-9"><div style="float:left;"><h3 style="margin:6px 0;">How are drugs selected for this trial?</h3></div></div><div class="col-xs-3"><div style="cursor:pointer;float:right;padding-top:3px;" data-target="#collapse1" data-toggle="collapse" id="collapse1Btn" onclick="toggleText('#collapse1Btn')">Expand</div></div></div></div><div class="panel-collapse collapse" id="collapse1"><div class="panel-body"><p>The selection process for ACTIV trials is described in detail in “Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines — <a href="https://journals.lww.com/ccmjournal/Fulltext/2021/11000/Accelerating_Coronavirus_Disease_2019_Therapeutic.13.aspx" title="Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines—Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials">Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials</a>.” For ACTIV-6, compounds were selected based on a number of factors, including known safety profiles, route of administration (oral drugs were prioritized for ACTIV-6), early clinical and real-world evidence of effectiveness in treating COVID-19, and level of public and scientific interest. See the <a href="https://journals.lww.com/ccmjournal/Fulltext/2021/11000/Accelerating_Coronavirus_Disease_2019_Therapeutic.13.aspx" title="Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines—Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials">article</a> and supplemental content for more details.</p><p>The first round of ACTIV-6 agent prioritization ended in April 2021. Four agents received high priority rankings and three of these agents — ivermectin, fluvoxamine and fluticasone — currently are being tested in ACTIV-6.</p><p>A second round to prioritize additional potential treatment candidates for ACTIV-6 was held in October 2021 so that replacement drugs will be available in the event that the ongoing arms are stopped early for safety or futility (e.g., lack of effect). Drug combinations — such as fluvoxamine/fluticasone and ivermectin/fluvoxamine — were considered in the second round of agent prioritization for ACTIV-6.</p></div></div></div></div><div class="question" id="question-two" name="question-two"><div class="panel panel-default"><div class="panel-heading" style="background-color:#006478;color:#fff;padding:5px 15px;"><div class="row"><div class="col-xs-9"><div style="float:left;"><h3 style="margin:6px 0;">What drugs currently are being studied in ACTIV-6?</h3></div></div><div class="col-xs-3"><div style="cursor:pointer;float:right;padding-top:3px;" data-target="#collapse2" data-toggle="collapse" id="collapse2Btn" onclick="toggleText('#collapse2Btn')">Expand</div></div></div></div><div class="panel-collapse collapse" id="collapse2"><div class="panel-body"><p>Enrollment is open to test the safety and effectiveness of ivermectin, fluvoxamine and fluticasone in treating mild to moderate COVID-19 symptoms at home. Agent prioritization is ongoing, and additional study arms may open. For the latest information on the drugs being studied, visit the ACTIV website.</p></div></div></div></div><div class="question" id="question-three" name="question-three"><div class="panel panel-default"><div class="panel-heading" style="background-color:#006478;color:#fff;padding:5px 15px;"><div class="row"><div class="col-xs-9"><div style="float:left;"><h3 style="margin:6px 0;">If the drugs to be tested in ACTIV-6 are approved already by the FDA and show some evidence of efficacy in COVID-19, why is a randomized, controlled clinical trial necessary?</h3></div></div><div class="col-xs-3"><div style="cursor:pointer;float:right;padding-top:3px;" data-target="#collapse3" data-toggle="collapse" id="collapse3Btn" onclick="toggleText('#collapse3Btn')">Expand</div></div></div></div><div class="panel-collapse collapse" id="collapse3"><div class="panel-body"><p>Anecdotal evidence and small observational studies are not enough to determine if a treatment is effective at relieving symptoms in mild to moderate COVID-19. Robust data from randomized, placebo-controlled clinical trials like ACTIV-6 are necessary for the FDA to approve the use of one or more of the ACTIV-6 drugs as a COVID-19 treatment and to inform specific, evidence-based guidance on how to effectively use the drugs as a COVID-19 treatment. See the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines for more information about ivermectin (page 125) and fluvoxamine (page 228).</p></div></div></div></div><div class="question" id="question-four" name="question-four"><div class="panel panel-default"><div class="panel-heading" style="background-color:#006478;color:#fff;padding:5px 15px;"><div class="row"><div class="col-xs-9"><div style="float:left;"><h3 style="margin:6px 0;">Is ivermectin a safe treatment for COVID-19?</h3></div></div><div class="col-xs-3"><div style="cursor:pointer;float:right;padding-top:3px;" data-target="#collapse4" data-toggle="collapse" id="collapse4Btn" onclick="toggleText('#collapse4Btn')">Expand</div></div></div></div><div class="panel-collapse collapse" id="collapse4"><div class="panel-body"><p>NIHs COVID-19 Treatment Guidelines Panel has determined that data are currently insufficient to recommend either for or against the use of ivermectin for treatment of COVID-19. Results from adequately powered, well-designed and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin in the treatment of COVID-19. Ivermectin is not authorized or approved by the FDA for prevention or treatment of COVID-19.</p></div></div></div></div><div class="question" id="question-five" name="question-five"><div class="panel panel-default"><div class="panel-heading" style="background-color:#006478;color:#fff;padding:5px 15px;"><div class="row"><div class="col-xs-9"><div style="float:left;"><h3 style="margin:6px 0;">When will results from ACTIV-6 be available?</h3></div></div><div class="col-xs-3"><div style="cursor:pointer;float:right;padding-top:3px;" data-target="#collapse5" data-toggle="collapse" id="collapse5Btn" onclick="toggleText('#collapse5Btn')">Expand</div></div></div></div><div class="panel-collapse collapse" id="collapse5"><div class="panel-body"><p>Enrollment is underway and results will be available shortly after the trial is completed — approximately 2 years — or possibly sooner, if analysis conducted during the trial indicates that one or more of the drugs is beneficial. When possible, interim results will be shared with other investigators or made public so that access to beneficial drugs can be accelerated.</p></div></div></div></div></div><p style="margin-top:10px;"><strong>About the National Center for Advancing Translational Sciences (NCATS):</strong> NCATS conducts and supports research on the science and operation of translation — the process by which interventions to improve health are developed and implemented — to allow more treatments to get to more patients more quickly. For more information about how NCATS helps shorten the journey from scientific observation to clinical intervention, visit <a href="https://ncats.nih.gov" rel="noopener" title="https://ncats.nih.gov">https://ncats.nih.gov</a>.</p><p><strong>About the National Institutes of Health (NIH):</strong> NIH, the nations medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <a href="https://www.nih.gov/" rel="noopener" title="https://www.nih.gov">https://www.nih.gov</a>.</p><p align="center"><em><strong>NIH…Turning Discovery Into Health<sup>®</sup></strong></em></p><p>&nbsp;</p><div class="sharethis-inline-share-buttons">&nbsp;</div><p>&nbsp;</p><script>
function toggleText(pn) {
var elem = document.querySelector(pn);
var target = document.querySelector(elem.getAttribute('data-target'));
if (elem.textContent === 'Expand') {
elem.textContent = 'Collapse';
target.classList.remove('collapse');
} else {
elem.textContent = 'Expand';
target.classList.add('collapse');
}
}
</script>
</div>
</div>
</div>
</div>
</article>
</div>
<div id="block-footercss" class="block block-block-content block-block-content2db33373-6fb7-49c5-be2f-83266eddea39">
<style type="text/css">
ul#superfish-navigation li { line-height:1.25; }
.region-header .block-superfish ul.sf-menu li a {padding-right:40px !important;}
@media (min-width: 1200px) {
ul.sf-menu.sf-navigation li.menuparent ul {width:280px !important;}
}
.main-content article .menu--navigation {
display:flex;
flex-wrap: nowrap;
justify-content: space-between;
align-items: stretch;
}
.main-content article .menu--navigation li {
flex: 1 1 0;
width: 0;
align-items: center;
display: flex;
justify-content: center;
}
.main-content article .menu--navigation li .dropdown-toggle {
white-space: unset;
}
.image-box img,
div.col-md-4.col-lg-2 img {
height: auto;
}
.caption-left-md {
float: left;
width: 50%;
margin: 0 1% 2% 0;
border: 1px solid #ddd;
}
.caption-left-md img {
width: 100%!important;
height: auto;
}
div.block.block-layout-builder.block-field-blocknodestafffield-divisions-office {
display: none
}
@media (max-width: 992px) {
.main-content article .menu--navigation {
flex-direction:column;
}
.main-content article .menu--navigation li {
display:inline-block;
margin:0;
padding:.25rem;
width: auto;
text-align:left;
}
.main-content article .menu--navigation li:hover, .main-content article .menu--navigation li.active {
border-bottom: 4px solid transparent !important;
}
.main-content article .menu--navigation li:hover a, .main-content article .menu--navigation li.active a {
border-bottom:4px solid #00626f !important;
padding-bottom:4px;
}
}
p.last-update-container {
font-size: 15px;
font-style: italic;
}
</style>
</div>
</div>
</div>
</div>
</div>
</main>
<div>
<div id="block-d9-subtheme-lastupdateblock" class="block block-ncats-common block-last-update-block">
<div class="container"><p class="last-update-container">Last updated on January 24, 2025</p></div>
</div>
</div>
<footer class="pt-4 footer mt-4">
<div class="container">
<div class="row">
<div class="col-12 py-4">
<img src="/sites/default/files/2023-10/ncats-logo-footer.png" class="img-fluid" alt="NCATS">
</div>
</div>
<div class="row">
<div class="container">
<div class="row justify-content-between">
<div class="col-xl-4">
<div class="pt-4">
<address>
9609 Medical Center Drive<br>
Rockville, MD 20850-9793<br>
301-594-8966<br>
<a href="mailto:ncatsinfo@nih.gov">ncatsinfo@nih.gov</a>
</address>
</div>
<div class="text-white social-links mt-4">
<h5>Connect with us</h5>
<ul id="social-media-icons" class="list-unstyled d-flex mb-4">
<li><a href="http://www.facebook.com/ncats.nih.gov" title="Visit us on Facebook" target="_blank"><i class="bi bi-facebook"></i></a></li>
<li><a href="https://www.linkedin.com/company/nih-ncats" title="Visit us on LinkedIn" target="_blank"><i class="bi bi-linkedin"></i></a></li>
<li><a href="http://www.twitter.com/ncats_nih_gov" title="Visit us on X" target="_blank"><i class="bi bi-twitter-x"></i></a></li>
<li><a href="http://www.youtube.com/user/ncatsmedia" title="View our videos on YouTube" target="_blank"><i class="bi bi-youtube"></i></a></li>
<li><a href="https://www.flickr.com/photos/64860478@N05/" target="_blank" title="View our photos on Flickr"><img src="/sites/default/files/2023-10/flickr.png" alt="View our photos on Flickr" style="height:24px;"></a></li>
</ul>
<p class="small">For <a href="http://edi.nih.gov/consulting/language-access-program/about" target="_blank">language access assistance</a>, contact the <a href="mailto:ncatsinfo@nih.gov">NCATS Public Information Officer</a></p>
</div>
</div>
<div class="col-xl-3 text-white mt-5 d-lg-none d-sm-none d-none d-xl-block">
<div id="mc_embed_shell">
<div id="mc_embed_signup">
<form action="https://nih.us5.list-manage.com/subscribe/post?u=e06bd55ccbb41f1a362306dff&amp;id=d32fa404b4&amp;f_id=0087b1edf0" method="post" id="mc-embedded-subscribe-form" name="mc-embedded-subscribe-form" class="validate" target="_blank">
<h5>Subscribe to NCATS News</h5>
<p>If you would like to stay up to date with the latest information from us, please sign up for NCATS News.</p>
<div id="mce-responses" class="clear">
<div class="response" id="mce-error-response" style="display: none;"></div>
<div class="response" id="mce-success-response" style="display: none;"></div>
</div>
<div class="input-group mb-3">
<input type="email" name="EMAIL" class="required email form-control" id="mce-EMAIL" required="" value="" placeholder="Enter Email" aria-label="Recipient's username" aria-describedby="button-addon2" tabindex="-1">
<div aria-hidden="true" style="position: absolute; left: -5000px;"><input type="text" name="b_e06bd55ccbb41f1a362306dff_d32fa404b4" tabindex="-1" value=""></div>
<button type="submit" name="subscribe" id="mc-embedded-subscribe" class="button btn" value="Subscribe">Submit</button>
</div>
</form>
</div>
<script type="text/javascript" src="//s3.amazonaws.com/downloads.mailchimp.com/js/mc-validate.js"></script><script type="text/javascript">(function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]='EMAIL';ftypes[0]='email';fnames[1]='FNAME';ftypes[1]='text';fnames[2]='LNAME';ftypes[2]='text';fnames[3]='SIGNUP';ftypes[3]='text';}(jQuery));var $mcj = jQuery.noConflict(true);</script></div>
</div>
</div>
</div>
</div>
</div>
<!-- footer menu section -->
<section class="footer-menu py-3 mb-xl-0 mb-lg-0 mb-sm-5 mt-4">
<div class="container">
<div class="row">
<div class="col-12">
<ul class="list-unstyled d-xl-flex d-lg-flex d-sm-block d-block justify-content-center mb-0">
<li><a href="https://ncats.nih.gov/">NCATS Home</a></li>
<li><a href="/sitemap">Site Map</a></li>
<li><a href="/privacy">Privacy Notice</a></li>
<li><a href="/comments">Comment Policy</a></li>
<li><a href="/accessibility">Accessibility</a></li>
<li><a href="/foia">FOIA</a></li>
<li><a href="http://oig.hhs.gov/" target="_blank">OIG</a></li>
<li class="border-0"><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" target="_blank">HHS Vulnerability Disclosure</a></li>
</ul>
</div>
</div>
</div>
</section>
</footer>
</div>
<script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/20079","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"eJx1j8EOwjAMQ3-o0DNfU2Vt1pWlzdSkbPt7OgkhQONi2c_yweHmpA06YUYLIqhiwgfCTbEWoAt02TV5MR1RKrMNtS1A11c0kTkSOoVoY5fffIU7bN8wG4Kdm7qQxPMD6265oGcy0hasY5LJvt0Zc9OxSkWx6GkvGYjEV8Ry3h-uf5V_7cKSNHFf76KY7QCCpskaxB3WjhUyrlznJ5W4glk","theme":"d9_subtheme","theme_token":null},"ajaxTrustedUrl":[],"gtm":{"tagId":null,"settings":{"data_layer":"dataLayer","include_classes":false,"allowlist_classes":"","blocklist_classes":"","include_environment":false,"environment_id":"","environment_token":""},"tagIds":["GTM-55CGV66V"]},"gtag":{"tagId":"G-ZZQ8H5G8ZX","otherIds":[],"events":[],"additionalConfigInfo":[]},"data":{"extlink":{"extTarget":true,"extTargetNoOverride":false,"extNofollow":false,"extNoreferrer":true,"extFollowNoOverride":false,"extClass":"ext","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":"","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":true,"extAlertText":"You are leaving the NIH website.\r\n\r\nThis external link provides additional information that is consistent with the intended purpose of this site. NIH cannot attest to the accuracy of a non-federal site.\r\n\r\nLinking to a non-federal site does not constitute an endorsement by NIH or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site\u0027s privacy policy when you follow the link.","mailtoClass":"mailto","mailtoLabel":"(link sends email)","extUseFontAwesome":false,"extIconPlacement":"append","extFaLinkClasses":"fa fa-external-link","extFaMailtoClasses":"fa fa-envelope-o","whitelistedDomains":[]}},"superfish":{"superfish-navigation":{"id":"superfish-navigation","sf":{"animation":{"opacity":"show","height":"show"},"speed":"fast"},"plugins":{"smallscreen":{"mode":"window_width","accordionButton":0,"title":"Navigation"},"supposition":true,"supersubs":true}}},"user":{"uid":0,"permissionsHash":"24b2a698a72e7a44d4f2d94d9880a6ba82bfbc8b8200dee23422144335254cbc"}}</script>
<script src="/core/assets/vendor/jquery/jquery.min.js?v=3.7.1"></script>
<script src="/core/assets/vendor/once/once.min.js?v=1.0.1"></script>
<script src="/core/misc/drupalSettingsLoader.js?v=10.2.3"></script>
<script src="/core/misc/drupal.js?v=10.2.3"></script>
<script src="/core/misc/drupal.init.js?v=10.2.3"></script>
<script src="/core/assets/vendor/tabbable/index.umd.min.js?v=6.2.0"></script>
<script src="https://cdn.jsdelivr.net/npm/@uswds/uswds@3.3.0/dist/js/uswds.min.js"></script>
<script src="/core/misc/progress.js?v=10.2.3"></script>
<script src="/core/assets/vendor/loadjs/loadjs.min.js?v=4.2.0"></script>
<script src="/core/misc/debounce.js?v=10.2.3"></script>
<script src="/core/misc/announce.js?v=10.2.3"></script>
<script src="/core/misc/message.js?v=10.2.3"></script>
<script src="/core/misc/ajax.js?v=10.2.3"></script>
<script src="/themes/custom/d9_subtheme/js/script.js?v=10.2.3"></script>
<script src="/modules/contrib/extlink/extlink.js?v=10.2.3"></script>
<script src="/modules/contrib/google_tag/js/gtm.js?srmo5o"></script>
<script src="/modules/contrib/google_tag/js/gtag.js?srmo5o"></script>
<script src="/modules/contrib/google_tag/js/gtag.ajax.js?srmo5o"></script>
<script src="/libraries/drupal-superfish/superfish.js?srmo5o"></script>
<script src="/libraries/drupal-superfish/jquery.hoverIntent.minified.js?srmo5o"></script>
<script src="/libraries/drupal-superfish/sfsmallscreen.js?srmo5o"></script>
<script src="/libraries/drupal-superfish/supposition.js?srmo5o"></script>
<script src="/libraries/drupal-superfish/supersubs.js?srmo5o"></script>
<script src="/modules/contrib/superfish/js/superfish.js?v=2.0"></script>
</body>
</html>